Delivery Order SPE2DB25D3109-SPE2DB25FPKUC
Award Date 7/16/25
Potential Completion Date 7/17/25
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat benign prostatic hyperplasia. The contract was awarded on August 12, 2025, under a firm fixed-price delivery order structure with a ceiling value of $1,601.60 and an ultimate completion date of August 13, 2025. This non-set-aside award was competitively procured and will be performed at AmerisourceBergen's headquarters in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,374.62 to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg. This non-competitive delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price pharmaceutical procurement contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a pharmaceutical commonly used to treat benign prostatic hyperplasia. This competitively awarded, non-set-aside delivery order was finalized on May 6, 2025, with a ceiling value of $2,043.31 and a firm fixed price structure. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat urinary symptoms associated with benign prostatic hyperplasia. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a ceiling value of $5,073.32 and an ultimate completion date of September 5, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,176.78 for 1,000 capsules of Tamsulosin HCL 0.4 mg on November 6, 2025, with completion targeted for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, valued at $2,702.16. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat benign prostatic hyperplasia. This competitive delivery order, valued at $2,750.29 with firm fixed pricing, was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract includes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,965.34 delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, with completion scheduled for June 9, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, with a contract value of $2,520.50. The award, issued on August 8, 2025, is a firm fixed price delivery order with an ultimate completion date of August 11, 2025. This is a non-set-aside, competitively awarded contract, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg at a ceiling value of $3,011.99. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, representing a routine pharmaceutical procurement for federal medical supply needs. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug...